Bayer and Iambic partner on AI-driven small molecule drug discovery

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Bayer and Iambic partner on AI-driven small molecule drug discovery

Bayer and Iambic Collaborate to Advance Drug Discovery with AI

June 22, 2026 8:00 AM EDT

Collaboration focuses on small molecule discovery Bayer to leverage Iambics AI platform to address hard-to-drug targets Collaboration will strengthen Bayers research and development portfolio by harnessing AI to accelerate drug discovery

BERLIN & SAN DIEGO--(BUSINESS WIRE)-- Bayer and Iambic Therapeutics Inc., a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced a drug discovery collaboration in which Bayer will discover new medicines using Iambics AI-driven platform. The collaboration is focused on small molecule discovery.

The collaboration will leverage Iambics AI-driven drug discovery... More